LESCH-NYHAN SYNDROME (X-LINKED RECESSIVE DISORDERS SERIES 1)

-
Hi Folks!! Follow our blog on Instagram LAB IN THE BOX
Lesch-Nyhan syndrome is a condition that occurs almost exclusively in males. It is characterized by neurological and behavioural abnormalities and the overproduction of uric acid. Uric acid accumulation can also cause kidney and bladder stones. The prevalence of Lesch-Nyhan syndrome is approximately 1 in 380,000 individuals. This condition occurs with a similar frequency in all populations.

SIGNS AND SYMPTOMS
 The symptoms of Lesch-Nyhan syndrome may become apparent as early as six months of age. Earlier urate crystal formation, resulting from abnormally increased uric acid levels in the urine, leads to the presence of orange-coloured deposits in the diapers of infants with this disorder. This may be the first manifestation of Lesch-Nyhan syndrome, but it is seldom recognized in early infancy.
In older children with this disorder, deposits of sodium urate in cartilaginous tissues in joints and the ears; in the ears, they form visible bulges called tophi. This is the picture commonly known as gout. 
Neurological symptoms associated with Lesch-Nyhan syndrome usually begin before the age of 12 months. People with this syndrome experience nervous system-related issues. The nervous system and behavioural disturbances experienced by people with Lesch-Nyhan syndrome include Abnormal involuntary muscle movements, Tensing of various muscles (dystonia), Jerking movements (chorea) and Eratical movement of the limbs (ballismus).
The most striking feature of Lesch-Nyhan syndrome, which has been observed in approximately 85 per cent of patients, is Self-injurious behaviour, which may include repeated biting of the lips, fingers, and/or hands, and repetitive banging of the head against hard objects. Some children may scratch their faces repeatedly. However, individuals with Lesch-Nyhan syndrome are not insensitive to pain. Additional behavioural abnormalities include aggressiveness, vomiting, and spitting. Self-injurious behaviours regularly lead to loss of tissue.

CAUSES
Mutations in the HPRT1 gene cause Lesch-Nyhan syndrome. The HPRT1 gene provides instructions for making an enzyme called hypoxanthine phosphoribosyltransferase 1. This enzyme is responsible for recycling purines. HPRT1 gene mutations that cause Lesch-Nyhan syndrome result in a severe shortage (deficiency) or complete absence of hypoxanthine phosphoribosyltransferase 1. When this enzyme is lacking, purines are broken down but not recycled, producing abnormally high levels of uric acid. Some people with HPRT1 gene mutations produce some functional enzymes. These individuals are said to have the Lesch-Nyhan variant. The signs and symptoms of the Lesch-Nyhan variant are often milder than those of Lesch-Nyhan syndrome and do not include self-injury.

DIAGNOSIS
The diagnosis of Lesch-Nyhan syndrome may be confirmed by a thorough clinical evaluation, including a detailed patient history and specialized blood tests. Molecular genetic testing for the HPRT1 gene is available to determine the specific disease-causing mutation. Carrier testing for Lesch-Nyhan syndrome is possible using molecular genetic testing.

TREATMENT
The treatment of Lesch-Nyhan syndrome is directed toward the specific symptoms that are apparent in each individual. 
The drug allopurinol is used to control the excessive amounts of uric acid associated with Lesch-Nyhan syndrome and control symptoms associated with excessive amounts of uric acid.
When kidney stones are present, they may be treated with extracorporeal shock wave lithotripsy (ESWL).
No sustained treatment or drug therapy has proven uniformly effective for the treatment of the neurological problems associated with Lesch-Nyhan syndrome. Baclofen or benzodiazepines have been used to treat spasticity. Diazepam may be useful.

Comments

Post a Comment

Popular posts from this blog

ONCOLOGY_2_MELANOMA

-
Image
Hi Folks!! Follow our blog on Instagram  LAB IN THE BOX MELANOMA What is Melanoma? Melanoma is a form of skin cancer arising from melanocytes, the pigment-producing cells in the skin. While it is less common than other skin cancers, it is significantly more dangerous due to its ability to spread (metastasize) to other parts of the body if not caught early. Causes and Risk Factors The primary cause of melanoma is exposure to ultraviolet (UV) radiation from the sun or tanning beds. Factors that increase the risk of melanoma include: - Fair Skin : Less melanin provides less protection from UV radiation. - History of Sunburns : Severe, blistering sunburns, especially in early life, increase risk. - Excessive UV Exposure : Frequent use of tanning beds or extensive sun exposure. - Family History : A family history of melanoma increases risk. - Moles : Having many moles or unusual moles can be a risk factor. - Weakened Immune System : Immunocompromised individuals are at higher risk. Sign...
Read more

Warmer climate may Drive Fungi to be more dangerous to our Health!!

-
Image
  Warmer climate may Drive Fungi to be more dangerous to our Health!! The world is filled with tiny creatures that sometimes found it delicious. Bacteria and viruses are so obvious that they are pathogenic . However recent news from Duke University School of medicine found that raised temperature  cause a pathogenic fungus known as Cryptococcus deneoformans to turn its adaptative responses into overdrive. This increases its number of genetic changes, some of which might presumably lead to higher heat resistance, and others perhaps toward greater disease-causing potential . " Fungal diseases are on the rise, largely because of an increase in the number of people who have weakened immune systems or underlying health conditions," Gusa said. But at the same time, pathogenic fungi may be adapting to warmer temperatures as well. Materials  provided by  Duke University .                             ...
Read more

History of Biotechnology

-
Image
HISTORY OF BIOTECHNOLOGY: People have been harnessing biological processes to improve their quality of life for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans began to tap the biological processes of microorganisms in order to make bread, alcoholic beverages, and cheese and to preserve dairy products. But such processes are not what is meant today by biotechnology, a term first widely applied to the molecular and cellular technologies that began to emerge in the 1960s and ’70s. A fledgling “biotech” industry began to coalesce in the mid- to late 1970s, led by Genentech, a pharmaceutical company established in 1976 by Robert A. Swanson and Herbert W. Boyer to commercialize the recombinant DNA technology pioneered by Boyer, Paul Berg, and Stanley N. Cohen. Early companies such as Genentech, Amgen, Biogen, Cetus, and Genex began by manufacturing genetically engineered substances primarily for medical and environmental uses. For ...
Read more